| Literature DB >> 25553262 |
Fabio Cibella1, Giuliana Ferrante1, Giuseppina Cuttitta1, Salvatore Bucchieri1, Mario R Melis1, Stefania La Grutta1, Giovanni Viegi1.
Abstract
PURPOSE: Rhinitis and conjunctivitis are common diseases worldwide that are frequently associated. Nevertheless, the risk factors for rhinoconjunctivitis are not well-described and the impact of conjunctivitis on rhinitis and asthma in children remains unknown. This study explored the different risk factors and evaluated the burden of rhinoconjunctivitis among adolescents.Entities:
Keywords: Rhinitis; asthma; children; conjunctivitis; epidemiology
Year: 2014 PMID: 25553262 PMCID: PMC4274469 DOI: 10.4168/aair.2015.7.1.44
Source DB: PubMed Journal: Allergy Asthma Immunol Res ISSN: 2092-7355 Impact factor: 5.764
General sample characteristics
| Overall | Males | Females | |
|---|---|---|---|
| Gender (No., %) | 2,150 | 1,057 (49.2) | 1,093 (50.8) |
| Age (mean±SD) | 12.59 (±1.04) | 12.60 (±1.05) | 12.59 (±1.03) |
| Height, cm (mean±SD) | 154.2 (±8.4) | 154.9 (±9.4) | 153.5 (±7.2) |
| Weight, kg (mean±SD) | 51.0 (±13.0) | 51.9 (±13.7) | 50.1 (±12.3) |
| Body Mass Index, kg/m2 (mean±SD) | 21.3 (±4.3) | 21.4 (±4.4) | 21.1 (±4.3) |
| Subjects with positive skin prick tests (No., %) | 842 (39.2) | 476 (45.0) | 366 (33.5)* |
| Subjects with 1 positive SPT (No., %) | 372 (17.3) | 200 (18.9) | 173 (15.8)* |
| Subjects with 2 positive SPTs (No., %) | 217 (10.1) | 128 (12.1) | 89 (8.1)* |
| Subjects with ≥3 positive SPTs (No., %) | 253 (11.8) | 148 (14.0) | 104 (9.6)* |
| Exposure to environmental tobacco smoke (No., %) | 1,216 (56.6) | 589 (55.7) | 627 (57.4) |
| Exposure to traffic† in the zone of residence (No., %) | 453 (21.1) | 211 (20.0) | 242 (22.1) |
| Mold/dampness exposure (No., %) | 322 (15.0) | 147 (13.9) | 175 (16.0) |
*P< 0.0001, χ2 test.
†(frequent or constant).
Frequency distribution of subjects without rhinitis or rhinoconjunctivitis, subjects with rhinitis, and subjects with rhinoconjunctivitis with respect to the presence/absence of current asthma
| Current asthma | |||
|---|---|---|---|
| No | Yes | Total sample | |
| No rhinitis, no rhinoconjunctivitis (N, %) | 1,296 (60.3) | 23 (1.1) | 1,319 (61.3) |
| Rhinitis (N, %) | 371 (17.3) | 20 (0.9) | 391 (18.2) |
| Rhinoconjunctivitis (N, %) | 393 (18.3) | 47 (2.2) | 440 (20.5) |
| Total sample (N, %) | 2,060 (95.8) | 90 (4.2) | 2,150 (100) |
Effect of personal and environmental characteristics on the prevalence of rhinitis and rhinoconjunctivitis
| No rhinitis, no rhinoconjunctivitis | Rhinitis | Rhinoconjunctivitis | ||
|---|---|---|---|---|
| Gender (No., M/F) | 655/641 | 192/179 | 160/233 | 0.0014 |
| Parental history for atopy (%) | 13.8 | 17.0 | 24.4 | < 0.0001 |
| Mold/dampness (%) | 12.8 | 15.6 | 19.6 | 0.003 |
| Exposure to environmental tobacco smoke (%) | 53.2 | 60.6 | 62.3 | 0.001 |
| Reported exposure to truck traffic (%) | 18.7 | 21.0 | 25.7 | 0.01 |
*χ2 test.
Frequency distribution of subjects without rhinitis or rhinoconjunctivitis, subjects with rhinitis, and subjects with rhinoconjunctivitis for each class of Atopic Index (0-no allergic sensitizations, 1-one positive skin test, 2-two positive skin tests, 3-three or more positive skin tests). Differences were significant (P < 0.0001, χ2 test)
| Atopic index | No rhinitis, no rhinoconjunctivitis | Rhinitis | Rhinoconjunctivitis |
|---|---|---|---|
| Class 0 (%) | 66.3 | 16.6 | 17.1 |
| Class 1 (%) | 61.7 | 20.4 | 17.9 |
| Class 2 (%) | 57.8 | 19.1 | 23.1 |
| Class 3 (%) | 49.8 | 22.0 | 28.2 |
Multiple logistic regression analysis of determinants for having conjunctivitis associated with rhinitis. Data are expressed as odds ratios (OR) and 95% confidence intervals (95% CI)
| OR | 95% CI | ||
|---|---|---|---|
| Female gender (ref. male) | 1.42 | 1.14-1.79 | 0.002 |
| Household crowding index (reference: <1) | 1.27 | 0.99-1.56 | 0.054 |
| Parental history for atopy (reference no history) | 2.01 | 1.53-2.65 | <0.0001 |
| Heavy traffic (ref. | 1.57 | 1.21-2.03 | 0.0006 |
| Mold/dampness (reference no exposure) | 1.56 | 1.17-2.10 | 0.003 |
| Exposure to environmental tobacco smoke (ref. no exposure) | 1.53 | 1.22-1.93 | 0.0003 |
| Allergen sensitization* | |||
| Sensitization to seasonal allergens (ref. no sensitization) | 0.95 | 0.4-1.96 | 0.90 |
| Sensitization to perennial allergens (ref. no sensitization) | 1.44 | 1.10-1.89 | 0.009 |
| Sensitization to seasonal+perennial allergens (ref. no sensitization) | 2.33 | 1.71-3.17 | <0.0001 |
*P for trend <0.0001.
Multiple logistic regression analysis of determinants for current asthma. Data are expressed as odds ratios (OR) and 95% confidence intervals (95% CI)
| OR | 95% CI | ||
|---|---|---|---|
| Gender (reference: female) | 1.36 | 0.86-2.16 | 0.19 |
| Heavy traffic (reference: | 1.74 | 1.08-2.80 | 0.024 |
| Mold/dampness (reference no exposure) | 1.65 | 0.96-2.83 | 0.72 |
| Exposure to environmental tobacco smoke (ref. no exposure) | 1.40 | 0.87-2.24 | 0.17 |
| Parental history for atopy (reference no history) | 4.92 | 2.97-8.16 | <0.0001 |
| Household crowding index (reference: <1) | 0.67 | 0.42-1.06 | 0.088 |
| Atopic index* | |||
| AI=1 (reference: AI=0) | 3.29 | 1.79-6.05 | 0.0001 |
| AI=2 (reference: AI=0) | 3.66 | 1.86-7.17 | 0.0002 |
| AI=3 (reference: AI=0) | 4.45 | 2.42-8.16 | <0.0001 |
| Rhinitis (ref.: neither rhinitis nor rhinoconjunctivitis)* | 2.28 | 1.21-4.30 | 0.010 |
| Rhinoconjunctivitis (ref.: neither rhinitis nor rhinoconjunctivitis)* | 5.23 | 3.06-8.96 | <0.0001 |
*P for trend <0.0001.
Effects of different combinations of allergic sensitization and disease status (presence of rhinitis/rhinoconjunctivitis) on current asthma prevalence
| Disease status | Allergic sensitization | Frequency distribution of different combination between disease status and allergic sensitization (%) | Prevalence of current asthma (%) |
|---|---|---|---|
| No rhinitis, no rhinoconjunctivitis | No | 41.4 | 0.7 |
| Rhinitis | No | 10.3 | 3.2 |
| Rhinoconjunctivitis | No | 10.7 | 4.8 |
| No rhinitis, No rhinoconjunctivitis | Yes | 21.5 | 3.7 |
| Rhinitis | Yes | 7.7 | 7.6 |
| Rhinoconjunctivitis | Yes | 8.4 | 17.3 |
Multiple logistic regression analysis for "moderate/high" rhinitis-related impact on quality of life. Data are expressed as odds ratios (OR) and 95% confidence intervals (95%CI)
| OR | 95% CI | ||
|---|---|---|---|
| Gender (reference: female) | 1.59 | 0.95-2.65 | 0.080 |
| Household crowding index (reference: <1) | 1.32 | 0.76-2.29 | 0.33 |
| Overweight-obesity* (ref.: normal weight) | 1.75 | 0.92-3.33 | 0.087 |
| Allergic sensitization (reference: none) | 0.84 | 0.50-1.41 | 0.51 |
| Current asthma (ref.: no current asthma) | 2.64 | 1.31-5.32 | 0.007 |
| Rhinoconjunctivitis (ref.: rhinitis) | 2.08 | 1.19-3.62 | 0.010 |
*Overweight-obese children were defined following the gender- and age-specific cut-off points by Cole et al.13